What’s News —

Corporate Intel

[Overheard]

Pharmalot

  • [image]

    CEO-Less Sanofi Tries to Regain Mojo

    As Sanofi’s chairman prepares to meet with investors in the wake of the CEO’s dismissal, one key question will be how it plans to rejuvenate its diabetes franchise, says Pharmalot columnist Ed Silverman.

Asia

Earnings

Economy

Health

Law

Media & Marketing

Management

CIO

CFO

R&C

Popular Now What's This?
Close

Content engaging our readers now, with additional prominence accorded if the story is rapidly gaining attention. Our WSJ algorithm comprises 30% page views, 20% Facebook, 20% Twitter, 20% email shares and 10% comments.

FOLLOW Corporate Intel on the go

WSJ.com/corporateintelligence on your smartphone or tablet

Partner Center
An Advertising Feature